Palladium-Catalyzed Annulation of Allenes with Indole-2-carboxylic Acid Derivatives: Synthesis of Indolo[2,3-c]pyrane-1-ones via Ar–I Reactivity or C–H … RR Suresh, KCK Swamy The Journal of Organic Chemistry 77 (16), 6959-6969, 2012 | 63 | 2012 |
Ligand design by targeting a binding site water P Matricon, RR Suresh, ZG Gao, N Panel, KA Jacobson, J Carlsson Chemical science 12 (3), 960-968, 2021 | 36 | 2021 |
An inexpensive cyclodiphosphazane as an efficient ligand for the palladium-catalyzed amination of aryl bromides and chlorides RR Suresh, KCK Swamy Tetrahedron Letters 50 (44), 6004-6007, 2009 | 35 | 2009 |
Exploring allene chemistry using phosphorus-based allenes as scaffolds KCK Swamy, M Anitha, G Gangadhararao, R Rama Suresh Pure and Applied Chemistry 89 (3), 367-377, 2017 | 26 | 2017 |
Activation of adenosine A2A or A2B receptors causes hypothermia in mice JL Carlin, S Jain, R Duroux, RR Suresh, C Xiao, JA Auchampach, ... Neuropharmacology 139, 268-278, 2018 | 22 | 2018 |
A1 Adenosine Receptor Agonists, Antagonists, and Allosteric Modulators ZG Gao, DK Tosh, S Jain, J Yu, RR Suresh, KA Jacobson The adenosine receptors, 59-89, 2018 | 21 | 2018 |
Pathophysiological Role and Medicinal Chemistry of A2A Adenosine Receptor Antagonists in Alzheimer’s Disease S Merighi, PA Borea, K Varani, F Vincenzi, A Travagli, M Nigro, ... Molecules 27 (9), 2680, 2022 | 17 | 2022 |
Nucleotide P2Y1 receptor agonists are in vitro and in vivo prodrugs of A1/A3 adenosine receptor agonists: implications for roles of P2Y1 and A1/A3 receptors … TE Liston, S Hinz, CE Müller, DM Holstein, J Wendling, RJ Melton, ... Purinergic Signalling 16, 543-559, 2020 | 17 | 2020 |
Design and in vivo activity of A3 adenosine receptor agonist prodrugs RR Suresh, S Jain, Z Chen Purinergic Signalling, 2020, 2020 | 16 | 2020 |
Molecularly nonstoichiometric crystals in phosphorus compounds M Chakravarty, R Rama Suresh, KC Kumara Swamy Inorganic chemistry 46 (23), 9819-9826, 2007 | 14 | 2007 |
Carbamoylphosphonates inhibit autotaxin and metastasis formation in vivo R Reich, A Hoffman, RR Suresh, O Shai, J Frant, A Maresca, CT Supuran, ... Journal of Enzyme Inhibition and Medicinal Chemistry 30 (5), 767-772, 2015 | 13 | 2015 |
Allosteric Antagonism of the A2A Adenosine Receptor by a Series of Bitopic Ligands ZG Gao, KS Toti, R Campbell, RR Suresh, H Yang, KA Jacobson Cells 9 (5), 1200, 2020 | 12 | 2020 |
Exploring organic reactions using simple cyclodiphosphazanes KCK Swamy, G Gangadhararao, RR Suresh, NNB Kumar, M Chakravarty Journal of Organometallic Chemistry 695 (7), 1042-1051, 2010 | 12 | 2010 |
Expanding the repertoire of methanocarba nucleosides from purinergic signaling to diverse targets KA Jacobson, V Salmaso, RR Suresh, DK Tosh RSC Medicinal Chemistry 12 (11), 1808-1825, 2021 | 10 | 2021 |
Structure–Activity Studies of 1H-Imidazo[4,5-c]quinolin-4-amine Derivatives as A3 Adenosine Receptor Positive Allosteric Modulators LB Fallot, RR Suresh, CL Fisher, V Salmaso, RD O’Connor, N Kaufman, ... Journal of medicinal chemistry 65 (22), 15238-15262, 2022 | 9 | 2022 |
Pharmacological characterization of DPTN and other selective A3 adenosine receptor antagonists ZG Gao, RR Suresh, KA Jacobson Purinergic Signalling 17, 737-746, 2021 | 8 | 2021 |
On the NHC/DBU-Mediated Tosyl Group Transfer to Allenes: Is There an Organocatalytic Role for DBU? KCK Swamy, RR Suresh, G Gangadhararao, M Anitha Synthesis 49 (10), 2275-2285, 2017 | 8 | 2017 |
Characterization of Dual-Acting A3 Adenosine Receptor Positive Allosteric Modulators That Preferentially Enhance Adenosine-Induced Gαi3 and GαoA Isoprotein … CL Fisher, LB Fallot, TC Wan, RF Keyes, RR Suresh, AC Rothwell, ... ACS Pharmacology & Translational Science 5 (8), 625-641, 2022 | 7 | 2022 |
Easy and stereoselective synthesis of cyclopropyl-substituted phosphonates via α-chlorophosphonates KCK Swamy, KVPP Kumar, RR Suresh, NS Kumar Synthesis 2007 (10), 1485-1490, 2007 | 7 | 2007 |
Selective A3 Adenosine Receptor Antagonist Radioligand for Human and Rodent Species RR Suresh, ZG Gao, V Salmaso, E Chen, RG Campbell, RB Poe, ... ACS Medicinal Chemistry Letters 13 (4), 623-631, 2022 | 6 | 2022 |